Delivery of systemic anti-cancer therapy during the COVID-19 pandemic.
Saved in:
| Title: | Delivery of systemic anti-cancer therapy during the COVID-19 pandemic. |
|---|---|
| Authors: | Fitzpatrick O; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland. orlafitzpatrick@rcsi.com.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland. orlafitzpatrick@rcsi.com., Ní Dhonaill R; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Linehan A; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Coyne Z; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Hennessy M; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Clarke M; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., McGee E; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Barrett F; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., O'Doherty D; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Matassa C; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Doyle T; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Christie A; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Hennessy B; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Grogan L; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Morris PG; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Breathnach OS; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland., Cowzer D; Medical Oncology Department, Beaumont Hospital, Dublin, Ireland.; Cancer Clinical Trials and Research Unit, Beaumont Hospital, Dublin, Ireland. |
| Source: | Irish journal of medical science [Ir J Med Sci] 2022 Apr; Vol. 191 (2), pp. 559-562. Date of Electronic Publication: 2021 May 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Royal Academy of Medicine of Ireland Country of Publication: Ireland NLM ID: 7806864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1863-4362 (Electronic) Linking ISSN: 00211265 NLM ISO Abbreviation: Ir J Med Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1863-4362 |
|---|---|
| DOI: | 10.1007/s11845-021-02631-1 |